Jiayong Xu

2.0k citations
18 papers · 1.4k indexed · h-index 14
Topics
Tuberculosis Research and Epidemiology (15 papers)Mycobacterium research and diagnosis (9 papers)Antibiotic Resistance in Bacteria (3 papers)
Partner nations
United StatesFranceChile

In The Last Decade

Jiayong Xu

18 papers receiving 1.4k citations

Peers

Jiayong Xu
Comparison fields: 5 of 77
  • Infectious Diseases 986
  • Epidemiology 798
  • Immunology 587
  • Molecular Biology 338
  • Surgery 213
Replace Nacho Aguiló with:
Nacho Aguiló Spain
Susan J. F. van den Eeden Netherlands
Bingdong Zhu China
Vladimir Yeremeev Russia
Hassan Safi United States
Andrés Baena Colombia
Maaike van Zon Netherlands
Christine Keller Germany
Joshua S. Woodworth United States
Jovanka Bestebroer Netherlands
Jiayong Xu relative to Nacho Aguiló Spain Nacho Aguiló's profile →
Citations per field
00.5×1.5×
Nacho Aguiló · 1×
Citations per year

Countries citing papers authored by Jiayong Xu

Since Specialization
Citations

This map shows the geographic impact of Jiayong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayong Xu more than expected).

Fields of papers citing papers by Jiayong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayong Xu. The network helps show where Jiayong Xu may publish in the future.

Co-authorship network of co-authors of Jiayong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayong Xu. A scholar is included among the top collaborators of Jiayong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayong Xu. Jiayong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 13
2 17
3 44
4 3
5 8
6 9
7 16
8 24
9 146
10 45
11 99
12 95
13 121
14 80
15 48
16 241
17 106
18 315

About Jiayong Xu

Jiayong Xu is a scholar working on Infectious Diseases, Molecular Medicine and Immunology, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (9 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Infectious Diseases (986 citations), Immunology (587 citations) and Epidemiology (798 citations). Jiayong Xu has collaborated with scholars based in United States, France and Chile. Frequent co-authors include John Chan, Paul J. Maglione, John Chan, JoAnn M. Tufariello, JoAnne L. Flynn, William R. Jacobs, Kathryn E. Tanaka, Soumya D. Chakravarty, Arturo Casadevall and Guofeng Zhu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026